SCHEMBL13805239

SCHEMBL13805239

CC1(C)c2cc(N(c3ccccc3)c3ccc(-c4nnc(-c5ccccc5)n4-c4ccccc4)cc3)ccc2-c2ccc(-n3c4ccccc4c4ccccc43)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
AVPR1A P37288 1/20 0.38
KDM4E B2RXH2 4/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GLA P06280 1/20 0.35
OPRD1 P41143 2/20 0.35
ALDH1A1 P00352 5/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
OXTR P30559 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 1/20 0.31
AKT1 P31749 1/20 0.31
HSD11B1 P28845 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
HDAC4 P56524 1/20 0.30
GFER P55789 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13805363 0.98 HPGD (0.36) HPGDSMN1; SMN2AVPR1AKDM4EATM
SCHEMBL13805330 0.98 HPGD (0.36) HPGDSMN1; SMN2AVPR1AKDM4EATM
SCHEMBL13805169 0.96 HPGD (0.38) HPGDSMN1; SMN2AVPR1AKDM4EATM
SCHEMBL13805256 0.94 HPGD (0.38) HPGDSMN1; SMN2AVPR1AKDM4EATM
SCHEMBL13805152 0.94 HPGD (0.37) HPGDSMN1; SMN2AVPR1AKDM4EATM
SCHEMBL13805349 0.92 HPGD (0.36) HPGDSMN1; SMN2AVPR1AKDM4EATM
SCHEMBL13805301 0.90 HPGD (0.36) HPGDSMN1; SMN2AVPR1AKDM4EATM
SCHEMBL13805035 0.90 HPGD (0.36) HPGDSMN1; SMN2AVPR1AKDM4EATM
SCHEMBL12367422 0.90 KDM4E (0.36) KDM4EATML3MBTL1HDAC4
SCHEMBL9881116 0.90 KDM4E (0.36) KDM4EATML3MBTL1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906518-B2 Triazole derivative, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-12-09 US disclosed
US-8906518-B2 Triazole derivative, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-12-09 US disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device GRIN3A, TEAD2, TBL3 HPGD 1843/4885SMN1; SMN2 4658/4885AVPR1A 2200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.